Type 2 Diabetes Therapeutics Pipeline Review, H2 2015 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/95q3qr/type_2_diabetes) has announced the addition of the "Type 2 Diabetes - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Multiple Myeloma (Kahler Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Type 2 Diabetes and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Type 2 DiabetesOverview
3. Therapeutics Development
4. Pipeline Products for Type 2 Diabetes- Overview
5. Pipeline Products for Type 2 Diabetes- Comparative Analysis
6. Type 2 Diabetes- Therapeutics under Development by Companies
7. Type 2 Diabetes- Therapeutics under Investigation by Universities/Institutes
8. Type 2 Diabetes- Pipeline Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Type 2 Diabetes- Products under Development by Companies
13. Type 2 Diabetes- Products under Investigation by Universities/Institutes
14. Type 2 Diabetes- Companies Involved in Therapeutics Development

Companies Mentioned - Sample List

• 3SBio Inc.
• Addex Therapeutics Ltd
• Adocia
• Advinus Therapeutics Ltd.
• Aegis Therapeutics, LLC
• AFFiRiS AG
• Alchemia Limited
• Alize Pharma SAS
• AlphaMab Co., Ltd
• Amarantus Bioscience Holdings, Inc.
• Ambrx, Inc.
• Amgen Inc.
• Anchor Therapeutics, Inc.
• AntriaBio, Inc.
• Aphios Corporation
• Araim Pharmaceuticals Inc.
• Arisaph Pharmaceuticals, Inc.
• ArisGen SA
• Array BioPharma Inc.
• Arrien Pharmaceuticals, LLC
• Artery Therapeutics, Inc.
• Astellas Pharma Inc.
• AstraZeneca Plc
• AUS Bio Limited
• Avaxia Biologics, Inc.
• Bayer AG
• Beta-Cell NV
• Betagenon AB
• Biocon Limited
• Biodel Inc.
• Biogenomics Limited
• BioLingus AG
• BioRestorative Therapies, Inc.
• BioTherapeutics Inc.
  

For more information visit http://www.researchandmarkets.com/research/95q3qr/type_2_diabetes